Carrier molecules for use in veterinary vaccines
Vaccine, ISSN: 0264-410X, Vol: 31, Issue: 4, Page: 596-602
2013
- 39Citations
- 125Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations39
- Citation Indexes38
- CrossRef38
- 36
- Policy Citations1
- Policy Citation1
- Captures125
- Readers125
- 125
Review Description
The practice of immunization of animals and humans has been carried out for centuries and is generally accepted as the most cost effective and sustainable method of infectious disease control. Over the past 20 years there have been significant changes in our ability to produce antigens by conventional extraction and purification, recombinant DNA and synthesis. However, many of these products need to be combined with carrier molecules to generate optimal immune responses. This review covers selected topics in the development of carrier technologies for use in the veterinary vaccine field, including glycoconjugate and peptide vaccines, microparticle and nanoparticle formulations, and finally virus-like particles.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0264410X12017173; http://dx.doi.org/10.1016/j.vaccine.2012.11.067; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84871938743&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23219438; https://linkinghub.elsevier.com/retrieve/pii/S0264410X12017173; https://dx.doi.org/10.1016/j.vaccine.2012.11.067
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know